[Management of aspirin discontinuation in stable coronary heart disease prior to elective surgery].
Collet
J P
JP
Service de Cardiologie, Hôpital de la Pitié-Salpêtrière, 47, boulevard de l'Hôpital, 75013 Paris.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D003327:Coronary Disease / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D017558:Elective Surgical Procedures / Q000009:adverse effects; D005480:Flurbiprofen / Q000008:administration & dosage; D006801:Humans; D054833:Isoindoles; D008657:Metabolic Clearance Rate; D010654:Phenylbutyrates / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D017410:Practice Guidelines as Topic; D011300:Preoperative Care / Q000379:methods* / Q000592:standards; D012307:Risk Factors; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D054833:Isoindoles; D010654:Phenylbutyrates; D010975:Platelet Aggregation Inhibitors; D005480:Flurbiprofen; C020371:indobufen; D001241:Aspirin